Atlas FDA

Altaviva™

FDA premarket approval P240011/S003 · decided 2025-11-26

Approval details

PMA number
P240011
Supplement
S003
Supplement type
Normal 180 Day Track No User Fee
Supplement reason
Location Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
Altaviva™
Generic name
Stimulator, tibial, electrical, implantable, for urinary incontinence
Applicant
Medtronic Neuromodulation
Date received
2025-10-16
Decision date
2025-11-26
Days to decision
41 days
Decision code
APPR
Product code
QPT
Advisory committee
Gastroenterology, Urology
Expedited review
No
Location
Minneapolis, MN
Statement
a manufacturing site change to add Medtronic Puerto Rico Operations Company, Villalba facility (MVC) as an alternate sterilization site for Neuromodulation/Pelvic Health (NMPH) Implantable Neurostimulators (INS), Drug Delivery Infusion Pumps (SynchroMed), Catheters and Accessories

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
SureTune4 Software (DEN210003)Medtronic Neuromodulation2021-08-23